Corrigendum to Resolvin D1 Attenuates Lipopolysaccharide Induced Acute Lung Injury Through CXCL-12/CXCR4 Pathway [J Surg Res. 2014 May 1;188(1):213-221]

The authors regret that Figure  1H included in the published version of the manuscript was inadvertently and incorrectly reported as representing the resolvin D1 single treatment group at 72 h. This section is actually from the resolvin D1 single treatment group at 24 h. The only correction is Figure 1H; the rest of the data, including the figures, are correct and the analysis and the final conclusion remain accurate. We apologize for this oversight and for any confusion that it has caused.

Source: Journal of Surgical Research - June 11, 2020 Category: Surgery Authors: Wang Yaxin, Yao Shanglong, Shu Huaqing, Liu Hong, Yuan Shiying, Chen Xiangdong, Li Ruidong, Wu Xiaoying, Guo Lina, Wang Yan Source Type: research